Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | BALAMINES FY26 | ALKYLAMINE FY26 | DEEPAKNTR FY26 | TECILCHEM FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 35.83× | — | 36.58× | — | 36.58× -2% | |
| P/B | ◆ 3.03× | — | 3.45× | — | 3.45× -12% | |
| EV/EBITDA | 22.71× | — | 21.65× | ◆ -75.02× | -26.68× +185% | |
| Market Cap | ₹5,990 Cr | — | ₹20,138 Cr | ₹16.2 Cr | ₹10,077 Cr -41% | |
| Growth | ||||||
| Revenue CAGR 3Y | -15.42% | — | ◆ -0.36% | — | -0.36% -4183% | |
| Revenue CAGR 5Y | 1.67% | — | ◆ 12.59% | 0.00% | 6.29% -73% | |
| Net Income CAGR 3Y | -25.29% | — | ◆ -13.54% | — | -13.54% -87% | |
| Revenue YoY (latest Q) | 27.23% | — | ◆ 61.75% | — | 61.75% -56% | |
| Net Income YoY (latest Q) | 113.86% | — | ◆ 234.89% | -171.61% | 31.64% +260% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 18.63% | — | 12.43% | — | 12.43% +50% | |
| Net Income Margin | ◆ 11.87% | — | 6.98% | -424700.00% | -212346.51% +100% | |
| Return on Common Equity | 8.85% | — | ◆ 9.81% | 2.30% | 6.05% +46% | |
| Return on Capital Employed | 9.37% | — | ◆ 10.65% | 7.44% | 9.04% +4% | |
| Return on Assets | ◆ 6.77% | — | 6.72% | -9.76% | -1.52% +545% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.06× | — | 0.26× | ◆ -0.69× | -0.21× +128% | |
| Interest Coverage | ◆ 38.93× | — | 16.43× | — | 16.43× +137% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,425 Cr | — | ₹7,887 Cr | ₹0 Cr | ₹3,944 Cr -64% | |
| Net Income | ₹169 Cr | — | ₹551 Cr | −₹0.4 Cr | ₹275 Cr -39% | |
| Total Assets | ₹2,743 Cr | ₹1,895 Cr | ₹8,681 Cr | ₹4.3 Cr | ₹3,527 Cr -22% | |
| EPS | ₹51.6 | — | ₹40.36 | ₹-0.22 | ₹20.07 +157% | |
| Book Value per Share | ₹610 | — | ₹427.92 | ₹-9.85 | ₹209.04 +192% | |